214 related articles for article (PubMed ID: 34295873)
1. Non-communicable Disease Surveillance in Malaysia: An Overview of Existing Systems and Priorities Going Forward.
Chandran A; Selva Kumar S; Hairi NN; Low WY; Mustapha FI
Front Public Health; 2021; 9():698741. PubMed ID: 34295873
[TBL] [Abstract][Full Text] [Related]
2. The Implementation of Childhood Obesity Related Policy Interventions in Malaysia-A Non Communicable Diseases Scorecard Project.
Mok WKH; Hairi NN; Chan CMH; Mustapha FI; Saminathan TA; Low WY
Int J Environ Res Public Health; 2021 Jun; 18(11):. PubMed ID: 34206056
[TBL] [Abstract][Full Text] [Related]
3. Assessing data availability of NCD prevention and control in six ASEAN countries based on WHO global monitoring framework and the progress monitor indicators.
Sornpaisarn B; Limmade Y; Pengpid S; Jayasvasti I; Chhoun P; Somphet V; Mustapha FI; Kaung KK; Chailek C; Bao TQ; Rehm J
BMC Public Health; 2023 Feb; 23(1):272. PubMed ID: 36750861
[TBL] [Abstract][Full Text] [Related]
4. Policies for type 2 diabetes and non-communicable disease management during the COVID-19 pandemic in Kenya and Tanzania: a desk review and views of decision-makers.
Mohamed SF; Kisia L; Mashiashi I; Mair F; Wisdom JP; Bunn C; Gray C; Kibe PM; Sanya RE; Karugu CH; Mtenga SM; Binyaruka P; Asiki G
BMJ Open; 2024 Mar; 14(3):e073261. PubMed ID: 38531573
[TBL] [Abstract][Full Text] [Related]
5. An Online Survey of the Perceptions of Clinical and Non-Clinical Professionals on Healthcare for Non-Communicable Diseases and COVID-19 Measures During the Pandemic in Malaysia.
Sureshkumar S; Mustapha F; Yusoff H; Mwangi KJ; Marcus K; Kohlbrenner B; Issom D; Benissa MR; Aebischer-Perone S; Braha N; Candela E; Chhabra KG; Desikachari BR; Dondi A; Etchebehere M; Gathecha G; Kengne AP; Missoni E; Palafox B; Pati S; Madhu PP; Peer N; Quint J; Tabrizi R; Oris M; Beran D; Balabanova D; Etter JF
Int J Public Health; 2023; 68():1605861. PubMed ID: 37304500
[No Abstract] [Full Text] [Related]
6. Monitoring and accountability for the Pacific response to the non-communicable diseases crisis.
Tolley H; Snowdon W; Wate J; Durand AM; Vivili P; McCool J; Novotny R; Dewes O; Hoy D; Bell C; Richards N; Swinburn B
BMC Public Health; 2016 Sep; 16(1):958. PubMed ID: 27613495
[TBL] [Abstract][Full Text] [Related]
7. China's Efforts on Management, Surveillance, and Research of Noncommunicable Diseases: NCD Scorecard Project.
Zhu XL; Luo JS; Zhang XC; Zhai Y; Wu J
Ann Glob Health; 2017; 83(3-4):489-500. PubMed ID: 29221521
[TBL] [Abstract][Full Text] [Related]
8. The potential long-term impact of the COVID-19 outbreak on patients with non-communicable diseases in Europe: consequences for healthy ageing.
Palmer K; Monaco A; Kivipelto M; Onder G; Maggi S; Michel JP; Prieto R; Sykara G; Donde S
Aging Clin Exp Res; 2020 Jul; 32(7):1189-1194. PubMed ID: 32458356
[TBL] [Abstract][Full Text] [Related]
9. A qualitative study of governance of evolving response to non-communicable diseases in low-and middle- income countries: current status, risks and options.
Rani M; Nusrat S; Hawken LH
BMC Public Health; 2012 Oct; 12():877. PubMed ID: 23067232
[TBL] [Abstract][Full Text] [Related]
10. A Global Cancer Surveillance Framework Within Noncommunicable Disease Surveillance: Making the Case for Population-Based Cancer Registries.
Piñeros M; Znaor A; Mery L; Bray F
Epidemiol Rev; 2017 Jan; 39(1):161-169. PubMed ID: 28472440
[TBL] [Abstract][Full Text] [Related]
11. Non-communicable disease policy implementation from 2014 to 2021: a repeated cross-sectional analysis of global policy data for 194 countries.
Allen LN; Wigley S; Holmer H; Barlow P
Lancet Glob Health; 2023 Apr; 11(4):e525-e533. PubMed ID: 36925173
[TBL] [Abstract][Full Text] [Related]
12. National noncommunicable disease monitoring survey (NNMS) in India: Estimating risk factor prevalence in adult population.
Mathur P; Kulothungan V; Leburu S; Krishnan A; Chaturvedi HK; Salve HR; Amarchand R; Nongkynrih B; Kumar PG; K S VU; Ramakrishnan L; Laxmaiah A; Boruah M; Kumar S; Patro BK; Raghav PR; Rajkumar P; Sarma PS; Sharma R; Tambe M; Thankappan KR; Arlappa N; Mahanta TG; Joshi RP; Rustagi N; Gupta S; Behera BK; Shelke SC; Galhotra A; Bhuyan PJ; Pakhare AP; Kumar D; Topno RK; Gupta MK; Trivedi AV; Garg S
PLoS One; 2021; 16(3):e0246712. PubMed ID: 33651825
[TBL] [Abstract][Full Text] [Related]
13. The role of collaborative, multistakeholder partnerships in reshaping the health management of patients with noncommunicable diseases during and after the COVID-19 pandemic.
Monaco A; Casteig Blanco A; Cobain M; Costa E; Guldemond N; Hancock C; Onder G; Pecorelli S; Silva M; Tournoy J; Trevisan C; Votta M; Yfantopoulos J; Yghemonos S; Clay V; Mondello Malvestiti F; De Schaetzen K; Sykara G; Donde S
Aging Clin Exp Res; 2021 Oct; 33(10):2899-2907. PubMed ID: 34319512
[TBL] [Abstract][Full Text] [Related]
14. What Happened to People with Non-Communicable Diseases during COVID-19: Implications of H-EDRM Policies.
Chan EYY; Kim JH; Lo ESK; Huang Z; Hung H; Hung KKC; Wong ELY; Lee EKP; Wong MCS; Wong SYS
Int J Environ Res Public Health; 2020 Aug; 17(15):. PubMed ID: 32756382
[TBL] [Abstract][Full Text] [Related]
15. Benefits and challenges of teleconsultation service for non-communicable disease follow-up in public healthcare clinics in Malaysia: a qualitative study.
Rambli R; Aznida FAA; Azimatun Noor A
Med J Malaysia; 2023 Jul; 78(4):449-457. PubMed ID: 37518911
[TBL] [Abstract][Full Text] [Related]
16. Incorporating selected non-communicable diseases into facility-based surveillance systems from a resource-limited setting in Africa.
Mocumbi AO; Langa DC; Chicumbe S; Schumacher AE; Al-Delaimy WK
BMC Public Health; 2019 Feb; 19(1):147. PubMed ID: 30717732
[TBL] [Abstract][Full Text] [Related]
17. Young Adults' Hopes Regarding Noncommunicable Disease (NCD) Prevention and Management After the SARS-CoV-2 Virus Pandemic: Reflections From the NCD Child #YouthCOVIDCHAT Campaign.
Gray NJ; Hauerslev M; Msengi G; Lewis-Watts L; Bhutta ZA
J Adolesc Health; 2024 Jan; 74(1):194-197. PubMed ID: 37737752
[TBL] [Abstract][Full Text] [Related]
18. Access to Medicines for Non-Communicable Diseases (NCDS) during COVID-19 in Kenya: A Descriptive Commentary.
Kiragu ZW; Gathecha G; Mwangi MK; Ndegwa Z; Pastakia S; Nyagah D; Cizungu RN; Takah Mutwiri M; Ndolo M; Wirtz VJ
Health Syst Reform; 2021 Jan; 7(1):e1984865. PubMed ID: 34748436
[TBL] [Abstract][Full Text] [Related]
19. What is the NCD service capacity and disruptions due to COVID-19? Results from the WHO non-communicable disease country capacity survey in the Americas region.
Luciani S; Caixeta R; Chavez C; Ondarsuhu D; Hennis A
BMJ Open; 2023 Mar; 13(3):e070085. PubMed ID: 36863746
[TBL] [Abstract][Full Text] [Related]
20. A Syndemic Perspective on the Management of Non-communicable Diseases Amid the COVID-19 Pandemic in Low- and Middle-Income Countries.
Yadav UN; Rayamajhee B; Mistry SK; Parsekar SS; Mishra SK
Front Public Health; 2020; 8():508. PubMed ID: 33102414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
